Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-044862
Filing Date
2024-11-12
Accepted
2024-11-12 17:24:47
Documents
5
Period of Report
2024-11-12

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 642107
2 formdef14a_001.jpg GRAPHIC 31686
3 formdef14a_002.jpg GRAPHIC 34175
4 proxy_001.jpg GRAPHIC 298787
5 proxy_002.jpg GRAPHIC 446456
  Complete submission text file 0001493152-24-044862.txt   1760763
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15771 | Film No.: 241450013
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)